TABLE 3.
V. cholerae gene products identified by RIVET as being transcriptionally induced during infection of the infant mouse small intestine compared to during growth in LB broth
Gene producta: | Cassetteb | Allelec | % of CFU resolved
|
Ratiof | No. of miceg | P valueh | |
---|---|---|---|---|---|---|---|
In vitrod | In vivoe | ||||||
VCA1008 | res | tnpRmut135 | <0.1 | 77 | 770 | 4 | <0.05 |
VC2487 | res1 | tnpRmut168 | <0.1 | 72 | 720 | 4 | <0.05 |
VC2641 | res1 | tnpRmut135 | <0.1 | 70 | 700 | 4 | <0.05 |
VC0488 | res | tnpRmut168 | <0.1 | 22 | 221 | 4 | <0.05 |
VC0063 | res1 | tnpRmut135 | 0.1 | 22 | 220 | 4 | <0.05 |
VCA1057 | res | tnpRmut135 | 0.3 | 35 | 117 | 4 | <0.05 |
VCA0773 | res1 | tnpRmut168 | 1 | 100 | 100 | 7 | <0.05 |
VC0622 | res1 | tnpRmut168 | 0.1 | 10 | 100 | 4 | <0.05 |
VC1111 | res | tnpRmut135 | <1 | 87 | 87 | 6 | <0.05 |
VC0207 | res | tnpRmut168 | <0.1 | 8 | 80 | 8 | 0.2 |
VC0721 | res1 | tnpRmut135 | <0.1 | 4 | 40 | 4 | <0.05 |
VC1658 | res | tnpRmut168 | 3 | 88 | 30 | 4 | <0.05 |
VC2373 | res1 | tnpRmut168 | 0.1 | 3 | 30 | 4 | 0.1 |
VC0201 | res1 | tnpRmut135 | 0.6 | 17 | 28 | 4 | <0.05 |
VCA0529 | res | tnpR | 0.2 | 2 | 20 | 4 | <0.05 |
VC0874 | res1 | tnpR | <1 | 19 | 19 | 5 | <0.05 |
VC1173 | res | tnpRmut168 | 1 | 16 | 16 | 4 | 0.2 |
VC0202 | res1 | tnpR | 7 | 94 | 13 | 3 | <0.05 |
VC0203 | res1 | tnpRmut168 | 2 | 25 | 13 | 7 | <0.05 |
VC1137 | res | tnpRmut135 | <1 | 12 | 12 | 8 | <0.05 |
VC1535 | res | tnpR | 8 | 93 | 12 | 19 | <0.05 |
VC1275 | res | tnpR | 8 | 85 | 11 | 4 | <0.05 |
VC0130 | res1 | tnpRmut168 | 0.2 | 2 | 10 | 4 | 0.1 |
VC1338 | res1 | tnpR | 3 | 30 | 10 | 4 | 0.05 |
VC2621 | res | tnpRmut168 | 12 | 90 | 7.5 | 4 | <0.05 |
VCA0632 | res1 | tnpR | 11 | 77 | 7 | 3 | <0.05 |
VC2419 | res | tnpRmut135 | 5 | 34 | 6.8 | 4 | <0.05 |
VC1500 | res | tnpR | 10 | 66 | 6.6 | 4 | <0.05 |
VCA0752 | res | tnpRmut168 | 4 | 24 | 6 | 7 | <0.05 |
VCA0687 | res | tnpRmut168 | 0.2 | 1 | 5 | 4 | 0.05 |
VC2705 | res | tnpR | 3 | 12 | 4 | 4 | <0.05 |
VC1687 | res | tnpRmut135 | 5 | 18 | 3.6 | 4 | 0.07 |
VC2742 | res1 | tnpRmut168 | 1.4 | 5 | 3.6 | 4 | <0.05 |
VCA0016 | res1 | tnpRmut168 | 7 | 24 | 3.4 | 4 | <0.05 |
VCA0242 | res1 | tnpR | 2.5 | 8.4 | 3.4 | 4 | 0.1 |
VC2646 | res1 | tnpRmut135 | 8 | 18 | 2.2 | 3 | 0.07 |
VC2130 | res1 | tnpRmut168 | 35 | 76 | 2.2 | 4 | <0.05 |
VC1619.1 | res | tnpRmut168 | 13 | 25 | 1.9 | 8 | <0.05 |
VCA0014 | res | tnpRmut168 | 12 | 18 | 1.5 | 4 | 0.1 |
VC1034 | res1 | tnpR | 75 | 100 | 1.3 | 4 | <0.05 |
Gene product designation by the Institute for Genomic Research.
res or res1 cassette in GOA1245 or GOA1246 strain background, respectively.
Wild-type, mut168, or mut135 RBS mutant allele of tnpR gene fused to V. cholerae gene.
Percent resolved CFU determined after 11 generations in LB broth.
Percent resolved CFU determined after 24 h of infection in the infant mouse small intestine.
The ivi genes were ranked by their ratio of percent resolution in vivo/in vitro.
Number of mice used per experiment to determine percent resolution in vivo.
Calculated by Student's two-tailed t test between the percent resolution values obtained in vivo and in vitro.